Zobrazeno 1 - 10
of 51
pro vyhledávání: '"A B, Dobrovol'skiĭ"'
Autor:
N M Vorob'eva, O V Ermolina, T V Balakhonova, A B Dobrovol'skiĭ, E V Titaeva, A I Kirienko, E P Panchenko
Publikováno v:
Терапевтический архив, Vol 80, Iss 7, Pp 50-54 (2008)
Aim. To evaluate efficacy of 3 month therapy with warfarin in patients after an episode of deep vein thrombosis (DVT) and/or pulmonary artery thromboembolism (PATE), safety of the treatment. Material and methods. 26patients after DVT/PATE aged 18-74
Externí odkaz:
https://doaj.org/article/23558ee27dab4143934e4b54bfb432f4
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (3-4)
Aim of this study was to evaluate the role of physical rehabilitation to improve the quality of life (QOL) of people after kidney transplantation.Analyzes the results of treatment of 57 recipients (mean age 35 +/- 9.65 years) donor kidney at differen
Autor:
N M, Vorob'eva, E P, Panchenko, A B, Dobrovol'skiĭ, E V, Titaeva, O V, Ermolina, T V, Balakhonova, Z B, Khasanova, A Iu, Postnov, A I, Kirienko
Publikováno v:
Terapevticheskii arkhiv. 83(12)
To study effects of thrombin-activated fibrinolysis inhibitor (TAFI) on efficacy and safety of long-term anti-coagulant treatment in patients with venous thromboembolic complications (VTEC).A total of 111 patients with a history of an episode of deep
Autor:
E I, Chazov, O V, Rodnenkov, A V, Zorin, V L, Lakomkin, V V, Gramovich, O N, Vyborov, A G, Dragnev, A A, Timoshin, L I, Buriachkovskaia, A A, Abramov, A B, Dobrovol'skiĭ, G V, Maksimov, V P, Masenko, E V, Arzamastsev, V I, Kapel'ko, A F, Vanin
Publikováno v:
Kardiologiia. 51(11)
On the basis of earlier executed studies of hypotensive effect of dinitrosyl iron complexes (DNIC) with glutathione, the drug has been created in industrial conditions named oxacom. Preliminary pharmacological studies of oxacom have not revealed nega
Autor:
N M, Vorob'eva, E P, Panchenko, O V, Ermolina, T V, Balakhonova, A B, Dobrovol'skiĭ, E V, Titaeva, Z B, Khasanova, A Iu, Postnov, A I, Kirienko
Publikováno v:
Terapevticheskii arkhiv. 83(8)
To compare effects of prolongation of the treatment with therapeutic doses of enoxaparin to 1 month on recanalization of occlusively thrombosed deep veins (OTDV) of the limbs with results of standard therapy with unfractionated heparin (UFH). Both tr
Autor:
N M, Vorob'eva, E P, Panchenko, A B, Dobrovol'skiĭ, E V, Titaeva, Z B, Khasanova, N V, Konovalova, A Iu, Postnov, A I, Kirienko
Publikováno v:
Terapevticheskii arkhiv. 83(6)
To investigate frequency of carriage of genetic polymorphisms CYP2C9 and VKORC1 in patients with venous thromboembolic complications (VTEC) in Moscow population given warfarin treatment and effects of this carriage on stability of anticoagulation and
Autor:
N M, Vorob'eva, E P, Panchenko, A B, Dobrovol'skiĭ, E V, Titaeva, O V, Ermolina, T V, Balakhonova, A I, Kirienko
Publikováno v:
Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery. 17(1)
The study was aimed at comparing efficacy and safety of two diferent approaches to initial anticoagulant therapy: a standard approach (non-fractionated heparin [NFH]for not less than 5 days followed by changing over to warfarin) and an alternative on
Autor:
N M, Vorob'eva, E P, Panchenko, A B, Dobrovol'skiĭ, E V, Titaeva, Z B, Khasanova, N V, Konovalova, A Iu, Postnov, O V, Ermolina, T V, Balakhonova, A I, Kirienko
Publikováno v:
Kardiologiia. 50(12)
We followed for 18 months 90 patients who had had deep vein thrombosis (DVE) and/or pulmonary embolism (PE) and received therapy with anticoagulants either for 3-12 months or for indefinitely long time. During follow-up rate of recurrent DVE was 16.7
Autor:
D A, Sychev, I V, Ignat'ev, E S, Kropacheva, N V, Emel'ianov, V V, Milovanova, Iu A, Naumova, A V, Kosovskaia, O B, Dobrovol'skiĭ, A I, Tashenova, E P, Panchenko, V G, Kukes
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (3)
The study included 25 patients at high risk of thromboembolic complications. All of them were treated with acenocoumarol for 6 months under control of the frequency of hemorrhage and episodes of severe hypocoagulation (a more than 3-fold rise in INR)
Publikováno v:
Kardiologiia. 50(11)